• Investing Ideas
  • /
  • Indian Pharmaceuticals & Biotech Dollar's Gain Retailers' Pain
39 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BIOCON

Biocon
₹310.906.6%28.7%₹356.5b₹279.11PE30.9xE8.7%0.5%

524742

Caplin Point Laboratories
₹1,331.10-1.9%96.4%₹103.0b₹1,579.33PE23.1xE1.0%0.4%

524558

Neuland Laboratories
₹7,661.307.6%275.1%₹97.5b₹8,300.00PE31xE9.2%0.1%

SUVENPHAR

Suven Pharmaceuticals
₹669.603.5%42.1%₹168.1b₹685.50PE46xE9.8%0.3%

ORCHPHARMA

Orchid Pharma
₹1,059.55-3.0%164.8%₹54.7b₹1,130.00PE43.1xE41.2%n/a

500674

Sanofi India
₹8,679.456.5%58.8%₹191.7b₹9,497.60PE33.2xE9.2%1.9%

500124

Dr. Reddy's Laboratories
₹6,288.301.1%26.5%₹1.0t₹6,005.14PE20.1xE2.5%0.6%

SYNGENE

Syngene International
₹687.25-1.7%-0.4%₹274.1b₹725.13PE53.6xE14.4%0.07%

ERIS

Eris Lifesciences
₹890.250.8%42.8%₹121.9b₹1,080.63PE31.3xE16.3%0.8%

PFIZER

Pfizer
₹4,277.003.2%12.7%₹194.8b₹4,720.33PE39xE14.5%0.8%

500488

Abbott India
₹26,604.353.7%18.0%₹561.3b₹27,670.43PE49.3xE13.2%1.2%

APLLTD

Alembic Pharmaceuticals
₹994.65-0.3%77.4%₹196.5b₹937.69PE33.1xE15.7%0.8%

NATCOPHARM

NATCO Pharma
₹1,011.15-1.0%70.4%₹182.4b₹975.36PE14.2xE14.6%0.9%

GLS

Glenmark Life Sciences
₹841.1512.1%66.7%₹101.6b₹905.75PE21.9xE13.1%2.7%

SUPRIYA

Supriya Lifescience
₹418.601.2%91.6%₹31.9b₹401.00PE28xE21.6%0.1%

CIPLA

Cipla
₹1,420.051.0%52.1%₹1.1t₹1,452.76PE30.9xE11.5%0.6%

CONCORDBIO

Concord Biotech
₹1,658.901.4%n/a₹174.4b₹1,596.80PE57xE23.8%0%

MANKIND

Mankind Pharma
₹2,333.80-2.7%n/a₹947.2b₹2,186.42PE54.1xE18.7%n/a

SUNPHARMA

Sun Pharmaceutical Industries
₹1,519.00-0.08%56.0%₹3.6t₹1,573.74PE40.9xE15.9%0.8%

MARKSANS

Marksans Pharma
₹167.600.3%108.7%₹75.1bn/aPE24xE20.6%0.3%

AJANTPHARM

Ajanta Pharma
₹2,234.004.4%74.1%₹279.0b₹2,271.20PE38.2xE18.0%1.6%

ZYDUSLIFE

Zydus Lifesciences
₹988.003.9%90.0%₹959.5b₹844.61PE33.6xE8.4%0.6%

500257

Lupin
₹1,647.753.3%132.0%₹749.9b₹1,515.97PE41.9xE17.9%0.2%

BLUEJET

Blue Jet Healthcare
₹380.20-2.9%n/a₹67.3b₹430.00PE37.7xE25.9%n/a
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.